Excited to share our latest study published in @ScienceAdvances. With the An & Zhang labs @UTHealthHouston, we show that monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance immune responses in multiple KRAS-mutant lung cancer models.
https://t.co/nL75KoAgGe
Excited to share our latest study published in @ScienceAdvances. With the An & Zhang labs @UTHealthHouston, we show that monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance immune responses in multiple KRAS-mutant lung cancer models.
https://t.co/nL75KoAgGe
While our work has focused on the role of PCDH7 in lung cancer, PCDH7 is highly expressed in several other tumor types including pancreatic cancer, melanoma, & prostate cancers. PCDH7 has also been shown by others to promote brain metastasis.
Delighted to share my research journey, dreams & about our lab at @IGIBSocial in the first episode of the #MeetThePI series. Hopeful for awesome science with my awesome team. I plan to take a talented & passionate PhD student in December, please apply to IGIB if interested.
Thrilled to share that I’ll be starting my lab as an Assistant Professor and Endowed Scholar in @UTSWMedCenter Molecular Biology Dept this Fall! 🥳 We’ll study #peroxisomes#mitochondria#metabolism via the lens of neonatology👶🏻, a very exciting frontier in medicine! #neotwitter
Excited to share our latest work, out now in @CellCellPress! Led by @ZedaZhang, we uncover a convergent uPAR⁺ tumor ecosystem that creates broad vulnerability to CAR T cell therapy. A collaborative effort with @Michel_Sadelain and @Aveline_Filliol.
https://t.co/U3M9LECtaY
UTSW’s Kim Orth receiving the 2026 Earl and Thressa Stadtman Distinguished Scientist Award from Margaret Phillips and Joan Conaway. She gave a great lecture! @UTSWScience@utswnews@ASBMB#ASBMB26
UTSW’s Kim Orth receiving the 2026 Earl and Thressa Stadtman Distinguished Scientist Award from Margaret Phillips and Joan Conaway. She gave a great lecture! @UTSWScience@utswnews@ASBMB#ASBMB26
ONLINE now in @CellCellPress: A review by CRI's @Zhu_Lab about their #relentlessdiscovery and how somatic mutations are becoming a key discovery engine for disease genetics. Read more ➡️
https://t.co/eBm71TT67s